Publication | Closed Access

Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial

HepatologyViral HepatitisAntiviral ActivityPharmacologyHepatitis BHepatitisAntiviral TherapyPharmacotherapyLiver DiseaseAntiviral DrugMedicine